The baseline level of PD-L1 expression on COVID-19 monocytes and mDCs was increased compared to controls and the cells were unable to upregulate CD86, HLA-DR, and PD-L1 upon stimulation (Figure 3E,F). This evidence concerns the gene CD86 and COVID-19.